People: Aegerion Pharmaceuticals Inc (AEGR.O)
20 Dec 2013
Mr. Mark J. Fitzpatrick is Chief Financial Officer of Aegerion Pharmaceuticals Inc., since May 2011. From July 2007 to May 2011, Mr. Fitzpatrick served as Vice President and Chief Financial Officer of Proteon Therapeutics, Inc., a privately held biopharmaceutical company engaged in the development of products to treat cardiovascular disease. From August 2005 to May 2007, Mr. Fitzpatrick was Vice President, Chief Financial Officer, Treasurer and Assistant Secretary for RenaMed Biologics, Inc. Mr. Fitzpatrick previously held Chief Financial Officer positions with Dynogen Pharmaceuticals, Worldstreet Corporation, and Diacrin. Prior to those positions, Mr. Fitzpatrick held various financial management positions with Repligen Corp. and was a senior auditor with Arthur Andersen & Co. Mr. Fitzpatrick received his B.S. degree in accounting from Boston College and was awarded a CPA certificate from the Commonwealth of Massachusetts in 1987.
|Total Annual Compensation, USD||Long-Term Incentive Plans, USD||All Other, USD||Fiscal Year Total, USD|